Selames 45 mg spot-on solution for cats 2.6–7.5 kg

מדינה: אירלנד

שפה: אנגלית

מקור: HPRA (Health Products Regulatory Authority)

מרכיב פעיל:

Selamectin

זמין מ:

Krka, d.d., Novo mesto

קוד ATC:

QP54AA05

INN (שם בינלאומי):

Selamectin

כמות:

45 mg/pipette

טופס פרצבטיות:

Spot-on solution

סוג מרשם:

POM: Prescription Only Medicine as defined in relevant national legislation

איזור תרפויטי:

selamectin

מצב אישור:

Authorised

תאריך אישור:

2018-12-21

מאפייני מוצר

Health Products Regulatory Authority
20 April 2021
CRN00C74F
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Selames 45 mg spot-on solution for cats 2.6–7.5 kg
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
​
Each 0.75 ml pipette contains:
​
​
​
ACTIVE SUBSTANCE:
​
​
​
Selamectin
​45
​
mg
​
EXCIPIENTS:
​
​
​
Butylhydroxytoluene (E321)
​0.6
​
mg
​
For the full list of excipients, see section 6.1.
​
​
3 PHARMACEUTICAL FORM
Spot-on solution.
Clear, colourless to yellow to brown solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats (2.6–7.5 kg)
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES

TREATMENT AND PREVENTION OF FLEA INFESTATIONScaused by
_Ctenocephalides _spp. for one month following a single
administration. This is as a result of the adulticidal, larvicidal and
ovicidal properties of the product. The product is
ovicidal for 3 weeks after administration. Through a reduction in the
flea population, monthly treatment of
pregnant and lactating animals will also aid in the prevention of flea
infestations in the litter up to seven weeks of
age. The product can be used as part of a treatment strategy for flea
allergy dermatitis and through its ovicidal and
larvicidal action may aid in the control of existing environmental
flea infestations in areas to which the animal has
access.

TREATMENT OF EAR MITES (_Otodectes cynotis_).

TREATMENT OF BITING LICE INFESTATIONS (_Felicola subrostratus_)

TREATMENT OF ADULT ROUNDWORMS (_Toxocara cati_)

TREATMENT OF ADULT INTESTINAL HOOKWORMS (_Ancylostoma tubaeforme_)

PREVENTION OF HEARTWORM DISEASE
caused by _Dirofilaria immitis _with monthly administration.
4.3 CONTRAINDICATIONS
Do not use in animals under 6 weeks of age.
Do not use in cats that are suffering from concomitant disease, or are
debilitated and underweight (for size and age).
Do not use in cases of hypersensitivity to the active substance or to
any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPEC